These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5656616)

  • 81. [The effect of Iscador (Viscum praeparatum M.) on the Walker carcinosarcoma of the rat (author's transl)].
    Seitz W
    Wien Klin Wochenschr; 1975 Feb; 87(4):131-2. PubMed ID: 1130081
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors.
    Tarnowski GS; Cappuccino JG; Schmid FA
    Cancer Res; 1967 Jun; 27(6):1092-5. PubMed ID: 5229785
    [No Abstract]   [Full Text] [Related]  

  • 83. [Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during growth and anticoagulant exposure. An autoradiographic study].
    Kolomina SM; Pogodina LS; Chentsov IuS; Kudriashov BA; Vasil'eva TN
    Tsitol Genet; 1982; 16(5):68-73. PubMed ID: 7147343
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Effect of vasopressin gene expression on the growth of Walker 256 carcinosarcoma in rats].
    Khegaĭ II; Popova NA; Ivanova LN
    Genetika; 2006 Jul; 42(7):993-5. PubMed ID: 16915932
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The effect of B vitamin and protein intake of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
    Crim JA; Buskirk HH; Petering HG
    Cancer Res; 1967 Jun; 27(6):1109-14. PubMed ID: 6027201
    [No Abstract]   [Full Text] [Related]  

  • 86. [Cellular proliferation kinetics of Walker carcinosarcoma, Zajdela's ascitic hepatoma and their metastases to the lymph nodes].
    Kiseleva EG
    Eksp Onkol; 1985; 7(5):42-4. PubMed ID: 4065018
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bax/Bcl-2 protein expression ratio and leukocyte function are related to reduction of Walker-256 tumor growth after β-hydroxy-β-methylbutyrate (HMB) administration in Wistar rats.
    Kuczera D; Paro de Oliveira HH; Fonseca Guimarães Fde S; de Lima C; Alves L; Machado AF; Coelho I; Yamaguchi A; Donatti L; Naliwaiko K; Fernandes LC; Nunes EA
    Nutr Cancer; 2012; 64(2):286-93. PubMed ID: 22242972
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antitumor effect of chlorbutinpenicillin.
    Navashin SM; Fomina IP; Terent'eva TG
    Fed Proc Transl Suppl; 1965; 24(4):732-4. PubMed ID: 5213778
    [No Abstract]   [Full Text] [Related]  

  • 89. Methylazo and methylazoxy compounds; new types of antitumour agents.
    Bollag W; Kaiser A; Langemann A; Zeller P
    Experientia; 1964 Sep; 20(9):503. PubMed ID: 5856336
    [No Abstract]   [Full Text] [Related]  

  • 90. Synergic effect of NADP+ on the antitumor properties of low doses of 9 OH-ellipticine towards Walker cells.
    Malvy C; Paoletti C
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):863-5. PubMed ID: 6683654
    [No Abstract]   [Full Text] [Related]  

  • 91. TEMPERATURE-DEPENDENT HISTOTYPIC CHANGES IN WALKER CARCINOSARCOMA IN THE CHORIOALLANTOIS.
    LEIGHTON DJ; MERKOW L; JUSTH G
    Science; 1963 Sep; 141(3586):1181-2. PubMed ID: 14043360
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Anticoagulant treatment of rats with Walker 256 carcinosarcoma.
    Owen CA
    J Cancer Res Clin Oncol; 1982; 104(1-2):191-3. PubMed ID: 7130245
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The effect of oral oxyphenbutazone (Tandearil) on tumor growth and the level of the seromucoid fraction in rats bearing Walker 256 carcinoma.
    Macbeth RA; Fischer JD
    Can J Physiol Pharmacol; 1971 Dec; 49(12):1071-7. PubMed ID: 5142312
    [No Abstract]   [Full Text] [Related]  

  • 94. Potentiated cyclophosphane: experimental study of the effect on tumor development and efficiency of cytostatic therapy.
    Amosova EN; Zueva EP; Razina TG; Krylova SG; Shilova NV; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():107-10. PubMed ID: 12949669
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Changes of histological and proliferative indices in the Walker carcinoma with tumour size and distance from blood vessel.
    Brammer I; Zywietz F; Jung H
    Eur J Cancer (1965); 1979 Nov; 15(11):1329-36. PubMed ID: 527625
    [No Abstract]   [Full Text] [Related]  

  • 96. Improvement of therapeutic effects of cytosine-arabinoside on Walker-carcinosarcoma after different synchronization with hydroxyurea.
    Mattern J; Wayss K; Volm M
    Eur J Cancer (1965); 1978 May; 14(5):603-5. PubMed ID: 348480
    [No Abstract]   [Full Text] [Related]  

  • 97. Polymeric anions and biological activities. Effects on intramuscular and intraperitoneal Walker carcinosarcoma 256 of the rat.
    Hodnett EM; Tai JT
    J Med Chem; 1974 Dec; 17(12):1335-7. PubMed ID: 4427331
    [No Abstract]   [Full Text] [Related]  

  • 98. Differences in the growth of the Walker carcinoma in Sprague-Dawley and Wistar rats.
    Jensen G; Müntzing J
    Z Krebsforsch; 1970; 74(1):55-8. PubMed ID: 4254295
    [No Abstract]   [Full Text] [Related]  

  • 99. Observations on tumour cells in the circulating blood before and after chemotherapy.
    Döbrössy L
    Eur J Cancer (1965); 1968 Jan; 3(6):531-5. PubMed ID: 5636122
    [No Abstract]   [Full Text] [Related]  

  • 100. Changes in Walker 256 tumour following intraembryonic transplantation.
    Teitel S; Anghel E; Popp I
    Oncologia; 1965; 19(4):278-84. PubMed ID: 5864376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.